Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Kompier, R. Neels, P. Beyer, W. Hardman, T. Lioznov, D. Kharit, S. Kostinov, M.

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine

  • All age groups
  • Influenza
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Paul, P. Janjua, E. AlSubaie, M. Ramadorai, V. Mushannen, B. Vattoth, A. L. Khan, W. Bshesh, K. Nauman, A. Mohammed, I. Bouhali, I. Khalid, M. Zakaria, D.

Anaphylaxis and Related Events Post-COVID-19 Vaccination: A Systematic Review

  • All age groups
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ van Mulukom, V. Pummerer, L. J. Alper, S. Bai, H. Čavojov Farias, J. Kay, C. S. Lazarevic, L. B. Lobato, E. J. C. Marinthe, G. Pavela Banai, I. Šrol, J. Žeželj, I.

Antecedents and consequences of COVID-19 conspiracy beliefs: A systematic review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Mojadadi, M. S. Javadinia, S. A. Attarian, F. Samami, E. Sobhani, M.

Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination

  • Adults
  • Older adults
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Whited, N. Cervantes, J.

Antibodies Against SARS-CoV-2 in Human Breast Milk After Vaccination: A Systematic Review and Meta-Analysis

  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Soetedjo, Nanny Natalia M. Iryaningrum, Maria Riastuti Lawrensia, Sherly Permana, Hikmat

Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: A systematic review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Al Hajji, Y. Taylor, H. Starkey, T. Lee, L. Y. W. Tilby, M.

Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ou, X. Jiang, J. Lin, B. Liu, Q. Lin, W. Chen, G. Wen, J.

Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Cotache-Condor, C. Peterson, M. Asare, M.

Application of theoretical frameworks on human papillomavirus vaccine interventions in the United States: systematic review and meta-analysis

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Zhang, G. Kuang, S. Zhang, X.

Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...